Wayfinder Biosciences
6 known investors
Find your way into Wayfinder Biosciences
925 people in our graph share verified history with the Wayfinder Biosciences team — schools, employers, funds. One of them is your warm intro.
Wayfinder develops RNA-targeting small molecule therapies using expertise in RNA biophysics, molecular biology, and machine learning to discover treatments for currently incurable diseases.
Founders & leadership

Investors · 6
How we know: Notation Capital's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · Not right? Tell us
How we know: Social Starts's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · siliconlegal.com · Not right? Tell us
Frequently asked questions
- What does Wayfinder Biosciences do?
- Wayfinder develops RNA-targeting small molecule therapies using expertise in RNA biophysics, molecular biology, and machine learning to discover treatments for currently incurable diseases.
- Who founded Wayfinder Biosciences?
- Wayfinder Biosciences was founded by Jason Fontana, David Sparkman-Yager, Chuhern Hwang.
- Who are Wayfinder Biosciences's investors?
- Wayfinder Biosciences's investors include Notation Capital, Social Starts, BoxOne Ventures, Divergent Capital, Entrepreneur First, Exor Ventures.





